Literature DB >> 25851653

Large-Scale Examination of Factors Influencing Phosphopeptide Neutral Loss during Collision Induced Dissociation.

Robert Brown1, Scott A Stuart, Scott S Stuart, Stephane Houel, Natalie G Ahn, William M Old.   

Abstract

Collision-induced dissociation (CID) remains the predominant mass spectrometry-based method for identifying phosphorylation sites in complex mixtures. Unfortunately, the gas-phase reactivity of phosphoester bonds results in MS/MS spectra dominated by phosphoric acid (H3PO4) neutral loss events, suppressing informative peptide backbone cleavages. To understand the major drivers of H3PO4 neutral loss, we performed robust nonparametric statistical analysis of local and distal sequence effects on the magnitude and variability of neutral loss, using a collection of over 35,000 unique phosphopeptide MS/MS spectra. In contrast to peptide amide dissociation pathways, which are strongly influenced by adjacent amino acid side chains, we find that neutral loss of H3PO4 is affected by both proximal and distal sites, most notably basic residues and the peptide N-terminal primary amine. Previous studies have suggested that protonated basic residues catalyze neutral loss through direct interactions with the phosphate. In contrast, we find that nearby basic groups decrease neutral loss regardless of mobility class, an effect only seen by stratifying spectra by charge-mobility. The most inhibitory bases are those immediately N-terminal to the phosphate, presumably because of steric hindrances in catalyzing neutral loss. Further evidence of steric effects is shown by the presence of proline, which can dramatically reduce the presence of neutral loss when between the phosphate and a possible charge donor. In mobile proton spectra, the N-terminus is the strongest predictor of high neutral loss, with proximity to the N-terminus essential for peptides to exhibit the highest levels of neutral loss.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25851653      PMCID: PMC4509682          DOI: 10.1007/s13361-015-1109-y

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  41 in total

1.  Electrostatic repulsion hydrophilic interaction chromatography for isocratic separation of charged solutes and selective isolation of phosphopeptides.

Authors:  Andrew J Alpert
Journal:  Anal Chem       Date:  2007-11-21       Impact factor: 6.986

2.  Deriving the probabilities of water loss and ammonia loss for amino acids from tandem mass spectra.

Authors:  Shiwei Sun; Chungong Yu; Yantao Qiao; Yu Lin; Gongjin Dong; Changning Liu; Jingfen Zhang; Zhuo Zhang; Jinjin Cai; Hong Zhang; Dongbo Bu
Journal:  J Proteome Res       Date:  2007-12-20       Impact factor: 4.466

Review 3.  Application of electron transfer dissociation (ETD) for the analysis of posttranslational modifications.

Authors:  Julia Wiesner; Thomas Premsler; Albert Sickmann
Journal:  Proteomics       Date:  2008-11       Impact factor: 3.984

4.  Phosphorylation-specific MS/MS scoring for rapid and accurate phosphoproteome analysis.

Authors:  Samuel H Payne; Margaret Yau; Marcus B Smolka; Stephen Tanner; Huilin Zhou; Vineet Bafna
Journal:  J Proteome Res       Date:  2008-06-19       Impact factor: 4.466

5.  Building consensus spectral libraries for peptide identification in proteomics.

Authors:  Henry Lam; Eric W Deutsch; James S Eddes; Jimmy K Eng; Stephen E Stein; Ruedi Aebersold
Journal:  Nat Methods       Date:  2008-09-21       Impact factor: 28.547

6.  Leaving group and gas phase neighboring group effects in the side chain losses from protonated serine and its derivatives.

Authors:  G E Reid; R J Simpson; R A O'Hair
Journal:  J Am Soc Mass Spectrom       Date:  2000-12       Impact factor: 3.109

7.  Cleavage N-terminal to proline: analysis of a database of peptide tandem mass spectra.

Authors:  Linda A Breci; David L Tabb; John R Yates; Vicki H Wysocki
Journal:  Anal Chem       Date:  2003-05-01       Impact factor: 6.986

8.  Electrospray tandem mass spectrometric studies of phosphopeptides and phosphopeptide analogues.

Authors:  A Tholey; J Reed; W D Lehmann
Journal:  J Mass Spectrom       Date:  1999-02       Impact factor: 1.982

9.  Evaluation of the utility of neutral-loss-dependent MS3 strategies in large-scale phosphorylation analysis.

Authors:  Judit Villén; Sean A Beausoleil; Steven P Gygi
Journal:  Proteomics       Date:  2008-11       Impact factor: 3.984

10.  Mechanistic insights into the multistage gas-phase fragmentation behavior of phosphoserine- and phosphothreonine-containing peptides.

Authors:  Amanda M Palumbo; Jetze J Tepe; Gavin E Reid
Journal:  J Proteome Res       Date:  2008-01-09       Impact factor: 4.466

View more
  5 in total

1.  Neutral Loss Is a Very Common Occurrence in Phosphotyrosine-Containing Peptides Labeled with Isobaric Tags.

Authors:  Robert A Everley; Edward L Huttlin; Alison R Erickson; Sean A Beausoleil; Steven P Gygi
Journal:  J Proteome Res       Date:  2016-12-30       Impact factor: 4.466

2.  Mapping the Phosphorylation Pattern of Drosophila melanogaster RNA Polymerase II Carboxyl-Terminal Domain Using Ultraviolet Photodissociation Mass Spectrometry.

Authors:  Joshua E Mayfield; Michelle R Robinson; Victoria C Cotham; Seema Irani; Wendy L Matthews; Anjana Ram; David S Gilmour; Joe R Cannon; Yan Jessie Zhang; Jennifer S Brodbelt
Journal:  ACS Chem Biol       Date:  2016-12-01       Impact factor: 5.100

Review 3.  Recent advances in phosphoproteomics and application to neurological diseases.

Authors:  Justine V Arrington; Chuan-Chih Hsu; Sarah G Elder; W Andy Tao
Journal:  Analyst       Date:  2017-11-20       Impact factor: 4.616

Review 4.  Phosphoproteomics in the Age of Rapid and Deep Proteome Profiling.

Authors:  Nicholas M Riley; Joshua J Coon
Journal:  Anal Chem       Date:  2015-11-19       Impact factor: 6.986

Review 5.  Phosphopeptide Fragmentation and Site Localization by Mass Spectrometry: An Update.

Authors:  Clement M Potel; Simone Lemeer; Albert J R Heck
Journal:  Anal Chem       Date:  2018-12-05       Impact factor: 6.986

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.